Fund shareholders of vTv Therapeutics Inc
ISIN US9183852048 · United States · LEI 549300WQE5EI9R35SE66
- Fund shareholders
- 14
- Of which ETFs
- 1 13 other funds
- Value held
- 13.4M $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Select Biotechnology Portfolio Fidelity Select Portfolios | 260,391 | 8.7M $ | 0.16 % | as of May 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 60,763 | 2.3M $ | 0.00 % | as of Jun 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 31,402 | 1.2M $ | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 14,732 | 491.3K $ | 0.00 % | as of May 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 7,234 | 272.4K $ | 0.02 % | as of Jun 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 4,779 | 159.4K $ | 0.00 % | as of May 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 4,193 | 139.8K $ | 0.00 % | as of May 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 2,524 | 84.2K $ | 0.00 % | as of May 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 1,523 | 57.3K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 775 | 29.2K $ | as of Jun 30, 2026 ↗ | |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 486 | 18.3K $ | 0.01 % | as of Jun 30, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 236 | 7.6K $ | 0.00 % | as of Jul 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 88 | 3.3K $ | 0.00 % | as of Jun 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 11 | 355.9 $ | 0.00 % | as of Jul 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Select Biotechnology Portfolio Fidelity Select Portfolios | 0.16 % | as of May 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.02 % | as of Jun 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.01 % | as of Jun 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 0.00 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 0.00 % | as of Jun 30, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of May 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 14 | +1 | 389,137 | -3.8 % |
| 2026Q2 | 13 | +2 | 404,705 | +44.4 % |
| 2026Q1 | 11 | +1 | 280,303 | +17.4 % |
| 2025Q4 | 10 | 0 | 238,683 | -0.7 % |
| 2025Q3 | 10 | 0 | 240,472 | +1.0 % |
| 2025Q2 | 10 | 0 | 238,113 | +0.2 % |
| 2025Q1 | 10 | +1 | 237,604 | +303.0 % |
| 2024Q4 | 9 | +3 | 58,953 | +98.4 % |
| 2024Q3 | 6 | 0 | 29,711 | -0.1 % |
| 2024Q2 | 6 | -1 | 29,734 | +2.8 % |
| 2024Q1 | 7 | 28,930 |
Institutional managers
32 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | 298,496 | 11.8M $ | as of Mar 31, 2026 |
| FMR LLC | 260,391 | 10.3M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 206,288 | 8.2M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 163,000 | 6.5M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 148,314 | 5.9M $ | as of Mar 31, 2026 |
| Trails Edge Capital Partners, LP | 139,578 | 5.5M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 32,886 | 1.3M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 18,052 | 715.9K $ | as of Mar 31, 2026 |
| 683 Capital Management, LLC | 16,000 | 634.6K $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 13,389 | 531K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 13,350 | 529.5K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 12,602 | 499.8K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 10,666 | 423K $ | as of Mar 31, 2026 |
| Brevan Howard Capital Management LP | 7,531 | 298.7K $ | as of Mar 31, 2026 |
| Pathstone Holdings, LLC | 6,073 | 240.9K $ | as of Mar 31, 2026 |
| UBS Group AG | 5,636 | 223.5K $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 5,618 | 222.8K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,155 | 45.8K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 1,119 | 44.4K $ | as of Mar 31, 2026 |
| Farther Finance Advisors, LLC | 283 | 11.5K $ | as of Mar 31, 2026 |
| Strengthening Families & Communities, LLC | 173 | 6.9K $ | as of Mar 31, 2026 |
| BESSEMER GROUP INC | 112 | 4 $ | as of Mar 31, 2026 |
| Activest Wealth Management | 50 | 2K $ | as of Mar 31, 2026 |
| CoreCap Advisors, LLC | 45 | 1.8K $ | as of Mar 31, 2026 |
| ROYAL BANK OF CANADA | 40 | 2K $ | as of Mar 31, 2026 |
Declared shareholders of vTv Therapeutics Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Integrated Core Strategies (US) LLC and 3 others | 6.90 % | 269,874 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of vTv Therapeutics Inc". https://titelia.com/en/stocks/vtv-therapeutics-inc-US9183852048